Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer

NCT06152471 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Early-stage Breast Cancer
Diarrhea
Adverse Drug Event

Interventions

DRUG: SPC-flakes
DRUG: Salovum
DRUG: Placebo

Sponsor

Henrik Lindman